Clicky

Shanghai Fosun(SFOSF)

Description: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a healthcare company, researches, develops, manufactures, trades, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing and R&D, Healthcare Service, Medical Devices and Medical Diagnosis, Pharmaceutical Distribution and Retail, and Other business Operations. The company offers cardiovascular products, including alprostadil dried emulsion, heparin series preparation, meglumine adenosine cyclophosphate for injection, calcium dobesilate, Telmisartan, and pitavastatin calcium tablets; and deproteinized calf blood injection and quetiapine fumarate tablets for central nervous system. It also provides blood system therapeutics comprising hemocoagulase and cobamamide for injection; and metabolism and alimentary system therapeutics that include reduced glutathione series, febuxostat tablet, glimepiride, animal insulin and its formulation, recombinant human erythropoietin for injection, new compound aloe capsule, and thioctic acid injection products. In addition, the company offers anti-infection products and anti-tumor therapeutics; and API and intermediate products comprising amino acid, tranexamic acid, and clindamycin hydrochloride and heparin essence products, as well as vaccines. Further, it develops, manufactures, imports, exports, and sells medical equipment and devices, and diagnostic products; provides healthcare, hospital management, and consulting services; and researches and develops biopharmaceutical and chemical drugs, as well as engages in the retail and wholesale of medicines. The company was formerly known as Shanghai Fosun Industrial Co. Ltd. and changed its name to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in December 2004. The company was founded in 1994 and is based in Shanghai, China. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a subsidiary of Shanghai Fosun High Technology (Group) Co., Ltd.


Keywords: Healthcare Service Vaccines Diagnostic Products Insulin Metabolism Emulsion Medical Diagnosis Fosun International High Technology Hospital Management Amino Acid Calcium Offers Car Adenosine Intermediate Products Sun Pharmaceutical Chemical Drugs Diagnostic Product Heparin Recombinant Cardiovascular Products Pharmaceutical Distribution Sinopharm Group Fosun Pharmaceutical Erythropoietin Lpr Quetiapine Aloe Ranexa Anti Infection Products Avast Calf Statin Clindamycin Essence Products

Home Page: www.fosunpharma.com

Building A
Shanghai, 200233
China
Phone: 86 21 3398 7000


Officers

Name Title
Mr. Kexin Wang Exec. Co-Chairman
Mr. Yifang Wu Exec. Chairman
Ms. Xiaohui Guan Exec. Vice Chairman
Mr. Yuqing Chen Co-Pres & Co-CEO
Mr. Deyong Wen Joint Pres,CEO & Exec. Director
Ms. Jingping Mei Exec. Pres
Dr. Aimin Hui Exec. Pres
Mr. Shengli Li Exec. Pres
Ms. Xiaolei Wu VP & CFO
Ms. Jia Yan Director of the Accounting Department

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 12.837
Trailing PE: 17.15
Price-to-Book MRQ: 1.451
Price-to-Sales TTM: 0.3057
IPO Date:
Fiscal Year End: December
Full Time Employees: 36279
Back to stocks